Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Cancer|September 29, 2004
Invasive aspergillosis in patients with solid tumorsNorio Ohmagari, Isaam I Raad, Ray Hachem, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 15, 2018
Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic PatientsRita Wilson Dib, Ray Hachem, Anne-Marie Chaftari, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2006
Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilmIssam Raad, Hend Hanna, Tanya Dvorak, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent modelRay Hachem, Paul Bahna, Hend Hanna, et al.
Cancer|January 7, 2010
Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organismsGopi Rangaraj, Bruno P Granwehr, Ying Jiang, et al.
Medicine|September 12, 2009
Management of Bacillus bacteremia: the need for catheter removalRawan Kassar, Ray Hachem, Ying Jiang, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2017
Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with CancerRay Hachem, Ruth Reitzel, Kenneth Rolston, et al.
Diagnostic Microbiology and Infectious Disease|May 19, 2007
Correlation between early clinical response after catheter removal and diagnosis of catheter-related bloodstream infectionBassam Shukrallah, Hend Hanna, Ray Hachem, et al.
Diagnostic Microbiology and Infectious Disease|November 16, 2004
Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective studyIoannis Chatzinikolaou, Hend Hanna, Ray Hachem, et al.
Cancer|February 14, 2006
Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients: should the European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG) criteria be revised?Ray Hachem, David Sumoza, Hend Hanna, et al.
Pageof 13